Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Martin, Janicko"'
Autor:
Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Ariunzaya Tsedendamba, Slavomira Komarova, Peter Jarcuska
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 2, Pp 419-432 (2024)
In this review article, we summarize the most common clinical manifestations of Primary biliary cholangitis (PBC): pruritus, fatigue, osteoporosis, and dyslipoproteinemia and discuss their impact of the patients’ quality of life. More than half of
Externí odkaz:
https://doaj.org/article/9cc5e6aa9469492d93be44335f32cb71
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic disease characterized by the destruction of the small intrahepatic bile ducts, which can progress to liver cirrhosis. The gold standard in the treatment of PBC is ursodeoxycholic a
Externí odkaz:
https://doaj.org/article/e9910144228f4fc18a263cf2337ac793
Autor:
Ivan Pacuta, Sona Gancarcikova, Stanislav Lauko, Vanda Hajduckova, Martin Janicko, Vlasta Demeckova, Maria Rynikova, Petra Adamkova, Dagmar Mudronova, Lubos Ambro, Maria Fialkovicova, Daniela Nemetova, Izabela Bertkova
Publikováno v:
Applied Sciences, Vol 14, Iss 11, p 4856 (2024)
Objectives: The aim of this study was to confirm the effectiveness of FMT on the basis of optimum composition of the faecal microbiota of the donor for support therapy in patients with ulcerative colitis, and to observe the viability of the microbiot
Externí odkaz:
https://doaj.org/article/a6b0cc6255b5480d8fcbce448f8dd007
Autor:
Stanislav Lauko, Sona Gancarcikova, Gabriela Hrckova, Vanda Hajduckova, Zuzana Andrejcakova, Livia Kolesar Fecskeova, Izabela Bertkova, Emilia Hijova, Anna Kamlarova, Martin Janicko, Lubos Ambro, Monika Kvakova, Zuzana Gulasova, Ladislav Strojny, Gabriela Strkolcova, Dagmar Mudronova, Marian Madar, Vlasta Demeckova, Daniela Nemetova, Ivan Pacuta, Drahomira Sopkova
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 43 (2023)
Transplantation of faecal microbiota (FMT) is generally considered a safe therapeutic procedure with few adverse effects. The main factors that limit the spread of the use of FMT therapy for idiopathic inflammatory bowel disease (IBD) are the necessi
Externí odkaz:
https://doaj.org/article/7c44bdbe43684d4985bb8d7b830ef72e
Autor:
Sylvia Drazilova, Eduard Veseliny, Patricia Denisa Lenartova, Dagmar Drazilova, Jakub Gazda, Ivica Grgurevic, Martin Janicko, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
IgG4-related sclerosing cholangitis, a biliary manifestation of an IgG4-related disease, belongs to the spectrum of sclerosing cholangiopathies which result in biliary stenosis. It presents with signs of cholestasis and during differential diagnosis
Externí odkaz:
https://doaj.org/article/d320906d071c457e86f68c4cbb3fa7b6
Autor:
Jakub Gazda, Martin Janicko, Sylvia Drazilova, Ivica Grgurevic, Tajana Filipec Kanizaj, Tomas Koller, Beatrica Bodorovska, Maja Mijic, Ivana Mikolasevic, Ivana Knezevic Stromar, Branislav Kucinsky, Matej Gazda, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background. Ursodeoxycholic acid response score (URS) is a prognostic model that estimates the baseline probability of treatment response after 12 months of ursodeoxycholic acid (UDCA) therapy in patients with primary biliary cholangitis (PBC). Aim.
Externí odkaz:
https://doaj.org/article/069badd8a34845328fd1dec40843f2b8
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background. Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease with wide ranges of reported incidence and prevalence. Aim. To map the incidence and prevalence of PBC in European countries from 2000 through 2020. Metho
Externí odkaz:
https://doaj.org/article/42cd3ce3c6324e15b82d162977e6e69b
Publikováno v:
Biomedical Papers, Vol 159, Iss 4, Pp 661-665 (2015)
Background: Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored. Aim: To assess the ris
Externí odkaz:
https://doaj.org/article/2de213a266c041899b62ba3a3da1efac
Autor:
Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasova, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Background and Aims. Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. The aim of this study was to (i) explore the prevalence of impaired fasting glucose (IFG) and T2DM in patients wit
Externí odkaz:
https://doaj.org/article/df33a1c69b4f4e7892e384221b2e50f3
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. Sustained viral response (SVR) achievement led to decreasing incidence and prevalenc
Externí odkaz:
https://doaj.org/article/5683313100f84aaa9c541bf70764481d